<DOC>
	<DOCNO>NCT01602757</DOCNO>
	<brief_summary>This study measure amount lidocaine tetracaine blood 2- , 4- , 12-hour application 4 Synera patch 4 hour application 4 patch without heat .</brief_summary>
	<brief_title>Pharmacokinetic Study Synera Healthy Volunteers</brief_title>
	<detailed_description>The purpose study evaluate pharmacokinetic profile lidocaine tetracaine 2- , 4- , 12-hour application 4 Synera® patch 4-hour application 4 lidocaine/tetracaine patch without heat healthy adult subject monitor frequency nature adverse event . In addition determine pharmacokinetics one-time application 4 Synera® patch , steady-state pharmacokinetics model residual patch concentration lidocaine tetracaine determine .</detailed_description>
	<mesh_term>Lidocaine</mesh_term>
	<mesh_term>Tetracaine</mesh_term>
	<criteria>least 18 year age nonsmoker body mass index ( BMI ) ≥ 18.5 &lt; 30.0 know suspected hypersensitivity , allergy , contraindication compound present study drug , include lidocaine , tetracaine , local anesthetic . defect , injury dermatological disease condition skin area study drug apply . history current evidence hepatic impairment . failed urine drug screen . use administered local systemic anesthetic , include overthecounter product , within past 14 day . donate blood plasma within past 30 day . participated clinical research study within past 30 day . pregnant , breastfeeding , female childbearing potential practicing adequate birth control</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2012</verification_date>
</DOC>